-
Diagnostics World | The laboratory side of diagnostic blood testing has achieved extraordinary efficiency and precision through automation. The last few decades of technology have allowed labs to simplify and automate sample processing to streamline operations and remove opportunities for human error.
Oct 13, 2023
-
Diagnostics World | The feasibility and design of a randomized controlled trial (RCT) for evaluating multi-cancer detection (MCD) assays suited to population-based cancer screening is the aim of a pilot Vanguard Study being undertaken by the National Cancer Institute (NCI).
Oct 10, 2023
-
Diagnostics World | Beginning today, the research team at Children’s Mercy Kansas City is bringing long read sequencing to clinical care, following three years of research and testing of PacBio HiFi sequencing. The transition is expected to speed the diagnostics odyssey for critically ill patients and their families.
Oct 6, 2023
-
Diagnostics World | Soon it may be possible for people to walk into their doctor’s office anywhere in the world and learn from a fingerprick blood sample if they are genetically predisposed to developing osteoporosis. It will matter not if those individuals are anywhere near the age of menopause, or if they’re male or female, because the SNPs being measured were present from the day they were born and men are by no means immune to the condition.
Oct 4, 2023
-
Diagnostics World | Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness.
Oct 3, 2023
-
Diagnostics World | Paige and Microsoft aim to build the world’s largest image-based AI models for digital pathology and oncology; the GA4GH Board of Directors has elected Heidi Rehm to succeed Ewan Birney; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.
Sep 28, 2023
-
Diagnostics World | Moderna and Immatics launch a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need; Generate:Biomedicines secures huge funding to advance its AI platform; Ibex Medical Analysis’ Galen platform transforms cancer diagnostics with AI; more.
Sep 27, 2023